Current Operating Procedure for Bleomycin ElectroScleroTherapy of Low-Flow Vascular Malformations
Author Information
Author(s): Tobian Muir, Wohlgemuth Walter A, Cemazar Maja, Bertino Giulia, Groselj Ales, Ratnam Lakshmi A, McCafferty Ian, Wildgruber Moritz, Gebauer Bernhard, de Terlizzi Francesca, Zanasi Alessandro, Sersa Gregor
Hypothesis
Bleomycin ElectroScleroTherapy (BEST) can enhance the treatment of low-flow vascular malformations.
Conclusion
The proposed Current Operating Procedure standardizes the use of BEST for treating low-flow vascular malformations.
Supporting Evidence
- BEST is a new approach that combines bleomycin with electric pulses to treat vascular malformations.
- The procedure aims to standardize treatment for low-flow vascular malformations.
- Clinical reports suggest that BEST can reduce the number of treatments needed compared to conventional methods.
Takeaway
This study explains how doctors can use a special treatment called BEST to help kids and adults with certain blood vessel problems.
Methodology
The study outlines a protocol for using Bleomycin ElectroScleroTherapy, including patient selection, treatment procedures, and safety measures.
Limitations
The procedure is based on the experience of a few centers, and further research is needed to establish optimal dosages and treatment intervals.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website